(Q47644276)

4 February 2018

title

Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome. (English)

1 reference

4 February 2018

author name string

Joanna M Hill

1

1 reference

4 February 2018

Anne M Ades

2

1 reference

4 February 2018

Susan K McCune

3

1 reference

4 February 2018

Nadia Sahir

4

1 reference

4 February 2018

Elizabeth M Moody

5

1 reference

4 February 2018

Daniel T Abebe

6

1 reference

4 February 2018

Linda S Crnic

7

1 reference

4 February 2018

Douglas E Brenneman

8

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 February 2018

published in

Experimental Neurology

1 reference

4 February 2018

volume

183

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

56-65

1 reference

4 February 2018

Abnormal calcium homeostasis in astrocytes from the trisomy 16 mouse.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

A femtomolar-acting neuroprotective peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Neuropeptide Y immunoreactive neurons in murine trisomy 16 cortical cultures. Plasticity of expression and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Somatostatin expression in TS16 mouse brain cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

The neurobiologic consequences of Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Vasoactive intestinal peptide fibers innervate neuroendocrine dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

The complete structure of the rat VIP gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Evolutionary breakpoints on human chromosome 21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive intestinal peptide receptors in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Blockade of VIP during neonatal development induces neuronal damage and increases VIP and VIP receptors in brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Expression and fine mapping of murine vasoactive intestinal peptide receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Cerebral cortical astroglia from the trisomy 16 mouse, a model for down syndrome, produce neuronal cholinergic deficits in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

A mouse model for Down syndrome exhibits learning and behaviour deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Excitatory and inhibitory neurons express c-Fos in barrel-related columns after exploration of a novel environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Innervation of interneurons immunoreactive for VIP by intrinsically bursting pyramidal cells and fast-spiking interneurons in infragranular layers of juvenile rat neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Interphase FISH for rapid identification of a down syndrome animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900164-X

10.1016/S0014-4886(03)00164-X

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

12957488

1 reference

4 February 2018